Actively Recruiting
Early Detection of Significant Ureteropelvic Junction Obstruction in Infants Using Cortical Transit Time on Diuretic Renogram and Ultrasound
Led by Centre Hospitalier Universitaire de la Réunion · Updated on 2022-09-29
75
Participants Needed
5
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying ureteropelvic junction obstruction UPJO detected before birth, a condition where urine flow from the kidney is blocked, which can cause kidney damage if untreated. This study aims to find early markers of significant obstruction to better decide when surgery is needed. Currently, doctors use diuretic renography and ultrasound, but these methods often detect problems only after kidney damage begins. The study focuses on measuring cortical transit time CTT and positional changes in kidney measurements as potential early indicators. Participants will undergo bilateral ultrasonography to measure the antero-posterior renal pelvic diameter APRPD in different positions and diuretic renography to measure cortical transit time. These non-invasive imaging tests will be performed at specified intervals to assess kidney function and obstruction severity. The study will compare these two markers to evaluate their ability to predict worsening obstruction. Families of infants aged 4 to 8 weeks with a confirmed unilateral UPJO will be involved. Researchers will monitor changes in APRPD through ultrasound at 3, 6, and 12 months, focusing on whether an increase of 4 mm or more occurs in the first year. The study includes regular imaging and clinical assessments, with the goal to improve early diagnosis and management decisions, reducing unnecessary surgeries and better protecting kidney health.
CONDITIONS
Brief Title
CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome
Research Team
L
Lucie Auzanneau
V
Valérie Fontaine
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here